Biofilm formation by Candida albicans mutants for genes coding fungal proteins exhibiting the eight-cysteine-containing CFEM domain

FEMS Yeast Research

Volumn 6, Issue 7, 2006, Pages 1074-1084

  Pérez, Ana ^a   Pedrós, Beatriz ^a   Murgui, Amelia ^a   Casanova, Manuel ^a   López Ribot, José L ^b   Martínez, José P ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Biofilms; Candida albicans; CFEM domain; Fungal proteins; PGA10 RBT51 and WAP1 CSA1 genes; RBT5

Indexed keywords

COMMON IN SEVERAL FUNGAL EXTRACELLULAR MEMBRANE PROTEIN; CYSTEINE; FUNGAL PROTEIN; HYDROPHOBIN; HYDROPHOBIN TYPE II; MEMBRANE PROTEIN; PROTEIN CSA1P; PROTEIN RBT51P; PROTEIN RBT5P; PROTEIN WAP1P; UNCLASSIFIED DRUG;

BIOFILM; CANDIDA ALBICANS; CELL SURFACE; CELL WALL; CONFERENCE PAPER; CSA1 GENE; FUNGAL GENE; FUNGUS MUTANT; GENE FUNCTION; GENETIC CODE; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; NULL ALLELE; OPEN READING FRAME; PGA10 GENE; PLEIOTROPY; PROTEIN DOMAIN; RBT5 GENE; RBT51 GENE; WAP1 GENE;

BIOFILMS; CANDIDA ALBICANS; CLONING, MOLECULAR; FUNGAL PROTEINS; MUTATION; PROTEIN STRUCTURE, TERTIARY;

CANDIDA ALBICANS;

EID: 33750005840     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2006.00131.x     Document Type: Conference Paper

References (49)

1. Appella E, Weber IT & Blasi F (1988) Structure and function of epidermal growth factor-like regions in proteins. FEBS Lett 231: 1-4.
2. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA & Struhl K (1992) Current Protocols in Molecular Biology. Greene Publishing Associates and Wiley-Interscience, New York.
3. Bachmann SP, Ramage G, VandeWalle K, Patterson TF, Wickes BL & López-Ribot JL (2003) Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother 47: 3657-3659.
4. Baillie JS & Douglas LJ (1999a) Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol 310: 644-656.
5. Baillie GS & Douglas LJ (1999b) Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 48: 671-679.
6. Brand A, MacCallum DM, Brown AJ, Gow NA & Odds FC (2004) Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell 3: 900-909.
7. Braun BR, Head WS, Wang MX & Johnson AD (2000) Identification and characterization of TUP1-regulated genes in Candida albicans. Genetics 156: 31-44.
8. Calderone RA (ed). (2002) Candida and Candidiasis, 1st edn. ASM Press, Washington.
9. Calderone RA & Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9: 327-335.
10. Cannon RD & Chaffin WL (1999) Oral colonization by Candida albicans. Crit Rev Oral Biol Med 10: 359-383.
11. Casanova M, Gil ML, Cardeñoso L, Martínez JP & Sentandreu R (1989) Identification of wall-specific antigens synthesized during germ tube formation by Candida albicans. Infect Immun 57: 262-271.
12. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T & Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183: 5385-5394.
13. Crump JA & Collignon PJ (2000) Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 19: 1-8.
14. De Groot PW, Hellingwerf KJ & Klis FM (2003) Genome-wide identification of fungal GPI proteins. Yeast 20: 781-796.
15. de Repentigny L, Aumont F, Bernard K & Belhumeur P (2000) Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect Immun 68: 3172-317.
16. De Vries OM, Fekkes MP, Wösten HA & Wessels JG (1993) Insoluble hydrophobin complexes in the walls of Schizophyllum commune and other filamentous fungi. Arch Microbiol 159: 330-335.
17. Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11: 30-36.
18. Fonzi WA & Irwin MY (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717-728.
19. Gillum AM, Tsay EYH & Kirsch DR (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of Saccharomyces cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182.
20. Glee PM, Sundstrom P & Hazen KC (1995) Expression of surface hydrophobic proteins by Candida albicans in vivo. Infect Immun 63: 1373-1379.
21. Hazen KC & Hazen BW (1987) A polystyrene microsphere assay for detecting surface hydrophobicity variations within Candida albicans populations. J Microbiol Methods 6: 289-299.
22. Jones RN, Marshall SA, Pfaller MA, Wilke WW, Hollis RJ, Erwin ME, Edmon MP & Wenzel RP (1997) Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis 29: 95-102.
23. Kopecka M & Gabriel M (1992) The influence of Congo red on the cell wall and (1-3)-β-D-glucan microfibril biogenesis in Saccharomyces cerevisiae. Arch Microbiol 158: 115-126.
24. Kuhn DM, George T, Chandra J, Mukherjee PK & Ghannoum MA (2002) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46: 1773-1780.
25. Kulkarni RD, Kelkar HS & Dean RA (2003) An eight-cysteine-containing CFEM domain unique to a group of fungal membrane proteins. Trends Biochem Sci 28: 118-121.
26. Lamarre C, Deslauriers N & Bourbonnais Y (2000) Expression cloning of the Candida albicans CSA1 gene encoding amycelial surface antigen by sorting of Saccharomyces cerevisiae transformants with monoclonal antibody-coated magnetic beads. Mol Microbiol 35: 444-453.
27. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A & Fink GR (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.
28. Martínez JP, Gil ML, López-Ribot JL & Chaffin WL (1998) Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin Microbiol Rev 11: 121-141.
29. Masuoka J, Wu G, Glee PM & Hazen KC (1999) Inhibition of Candida albicans attachment to extracellular matrix by antibodies which recognize hydrophobic cell wall proteins. FEMS Immunol Med Microbiol 24: 421-429.
30. Mukherjee PK, Chandra J, Kuhn DM & Ghannoum MA (2003) Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 7: 4333-4340.
31. Murad AM, Lee PR, Broadbent ID, Barelle CJ & Brown AJ (2000) CIp10, an efficient and convenient integrating vector for Candida albicans. Yeast 16: 325-327.
32. O'Toole GA, Pratt LA, Watnick PI, Newman DK, Weaver VB & Kolter R (1999) Genetic approaches to study of biofilms. Methods Enzymol 310: 91-109.
33. O'Toole GA, Kaplan HB & Kolter R (2000) Biofilm formation as microbial development. Annu Rev Microbiol 54: 49-79.
34. Pérez A, Casanova M, Murgui A, López-Ribot JL & Martínez JP (2005) A family of hydrophobin-like molecules in Candida albicans with a role in biofilm formation. FEBS Advanced Lecture Course. Human fungal pathogens: molecular mechanisms of host-pathogen interactions and virulence, La Colle sur Loup, France.
35. Pfaller MAR, Jones RN, Doern GV, Sader HS, Hollis RJ & Messer SA (1998) The Sentry Participant Group. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY program. J Clin Microbiol 36: 1886-1889.
36. Pfaller MAR, Jones RN, Doern GV, Fluit AC, Verhoef J, Sader HS, Messer SA, Houston A, Coffman S & Hollis RJ (1999) International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagn Microbiol Infect Dis 35: 19-25.
37. Ram AFJ, Wolters A, Ten Hoopen R & Klis FM (1994) A new approach for isolating cell wall mutants in Saccharomyces cerevisiae by screening for hypersensitivity to Calcofluor white. Yeast 10: 1019-1030.
38. Ramage G, Wickes BL & López-Ribot JL (2001a) Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab 20: 42-44.
39. Ramage G, Vande Walle K, Wickes BL & López-Ribot JL (2001b) Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45: 2475-2479.
40. Ramage G, Bachmann S, Patterson TF, Wickes BL & López-Ribot JL (2002a) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49: 973-980.
41. Ramage G, VandeWalle K, López-Ribot JL & Wickes BL (2002b) The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 214: 95-100.
42. Ramage G, Saville SP, Thomas DP & López-Ribot JL (2005) Candida biofilms: an update. Eukaryot Cell 4: 633-638.
43. Saville SP, Lazzell AL, Monteagudo C & López-Ribot JL (2003) Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2: 1053-1060.
44. Weissman Z & Kornitzer D (2004) A family of Candida cell surface haem-binding proteins involved in haemin and haemoglobin-iron utilization. Mol Microbiol 53: 1209-1220.
45. Wessels JG (1994) Developmental regulation of fungal cell wall formation. Annu Rev Phytopathol 32: 413-437.
46. Wessels JG (1997) Hydrophobins: proteins that change the nature of the fungal surface. Adv Microb Physiol 38: 1-45.
47. Wösten HA (2001) Hydrophobins: multipurpose proteins. Annu Rev Microbiol 55: 625-646.
48. Wösten HA & de Vocht ML (2000) Hydrophobins, the fungal coat unravelled. Biochim Biophys Acta 1469: 79-86.
49. Yanisch-Perron C, Vieira J & Messing J (1985) Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp 18 and pUC19 vectors. Gene 33: 103-119.